POCN's Multiple Myeloma Center of Excellence - Multiple Myeloma: A POCN Center of Excellence

Multiple Myeloma Resources
Chosen by Advanced
Practice Providers

Clinical guidelines
Patient support and education resources
Research updates

CHIP Tied to Higher CVD Risk in Patients With Multiple Myeloma Undergoing HCT

Researchers of a study investigating the role of clonal hematopoiesis of indeterminate potential (CHIP) in cardiovascular disease (CVD) among patients with multiple myeloma (MM) undergoing hematopoietic stem cell...

CURATED BY: Laura J. Zitella,
MS, RN, ACNP-BC, AOCN

Laura J. Zitella

MS, RN, ACNP-BC, AOCN
Nurse Practitioner, Associate Clinical Professor, University of California San Francisco

Revealing Multiple Myeloma Origins: Premalignant Disorders and Biomarker Advances

Preexisting plasma cell disorders, such as monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM), are identified in at least one-third of patients with multiple myeloma (MM)....

CURATED BY:
Jill N. Burke,
CNP, DipACLM

Dexamethasone Dose Reductions in NDMM: No Impact on Survival Outcomes

Dexamethasone is a key component of induction therapy for newly diagnosed multiple myeloma (NDMM), but its use is often associated with toxicities such as hyperglycemia and insomnia....

CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Challenges and Hope in Treating RRMM: Insights from the LocoMMotion Study

Researchers from the LocoMMotion study examined real-world clinical practice treatments for patients with relapsed/refractory multiple myeloma (RRMM) exposed to proteasome inhibitors, immunomodulatory drugs, and anti-CD38 monoclonal antibodies....

CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Physician Associate and Nurse Practitioner Contributors to the Multiple Myeloma Center of Excellence

POCN’s Multiple Myeloma Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.

Donna D. Catamero,

ANP-BC, OCN, CCRC
Associate Director, Myeloma Research, Icahn School of Medicine at Mount Sinai

Laura J. Zitella,

MS, RN, ACNP-BC, AOCN
Nurse Practitioner, Associate Clinical Professor, University of California San Francisco

Jill N. Burke,

CNP, DipACLM
Nurse Practitioner, Massachusetts General Hospital

Danielle Roberts,

MS, MMSc, PA-C
Associate Chief of Education, Winship Cancer Institute of Emory University

Provided by an unrestricted grant from

Company
Contact

Partner with Us
Ambassador Program